(MedPage Today) — HOUSTON — Patients with polycythemia vera (PV) and a history of treatment with GLP-1 agonists had significantly lower rates of multiple adverse outcomes associated with the disease, a large propensity-matched study showed…
Source link : https://www.medpagetoday.com/meetingcoverage/soho/117312
Author :
Publish date : 2025-09-04 20:08:00
Copyright for syndicated content belongs to the linked Source.
